vs

Side-by-side financial comparison of Orion S.A. (OEC) and OMNICELL, INC. (OMCL). Click either name above to swap in a different company.

Orion S.A. is the larger business by last-quarter revenue ($411.7M vs $309.9M, roughly 1.3× OMNICELL, INC.). On growth, OMNICELL, INC. posted the faster year-over-year revenue change (14.9% vs -5.2%). Orion S.A. produced more free cash flow last quarter ($44.2M vs $38.6M). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (5.8% CAGR vs -9.5%).

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

OEC vs OMCL — Head-to-Head

Bigger by revenue
OEC
OEC
1.3× larger
OEC
$411.7M
$309.9M
OMCL
Growing faster (revenue YoY)
OMCL
OMCL
+20.1% gap
OMCL
14.9%
-5.2%
OEC
More free cash flow
OEC
OEC
$5.6M more FCF
OEC
$44.2M
$38.6M
OMCL
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
5.8%
-9.5%
OEC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OEC
OEC
OMCL
OMCL
Revenue
$411.7M
$309.9M
Net Profit
$11.4M
Gross Margin
18.9%
45.3%
Operating Margin
4.3%
60.1%
Net Margin
3.7%
Revenue YoY
-5.2%
14.9%
Net Profit YoY
EPS (diluted)
$-0.36
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OEC
OEC
OMCL
OMCL
Q1 26
$309.9M
Q4 25
$411.7M
$314.0M
Q3 25
$450.9M
$310.6M
Q2 25
$466.4M
$290.6M
Q1 25
$477.7M
$269.7M
Q4 24
$434.2M
$306.9M
Q3 24
$463.4M
$282.4M
Q2 24
$477.0M
$276.8M
Net Profit
OEC
OEC
OMCL
OMCL
Q1 26
$11.4M
Q4 25
Q3 25
$-67.1M
$5.5M
Q2 25
$9.0M
$5.6M
Q1 25
$9.1M
$-7.0M
Q4 24
Q3 24
$-20.2M
$8.6M
Q2 24
$20.5M
$3.7M
Gross Margin
OEC
OEC
OMCL
OMCL
Q1 26
45.3%
Q4 25
18.9%
41.5%
Q3 25
19.0%
43.3%
Q2 25
21.1%
43.9%
Q1 25
20.5%
41.1%
Q4 24
20.6%
46.2%
Q3 24
23.2%
43.3%
Q2 24
23.0%
41.3%
Operating Margin
OEC
OEC
OMCL
OMCL
Q1 26
60.1%
Q4 25
4.3%
0.1%
Q3 25
-11.9%
2.7%
Q2 25
6.9%
2.8%
Q1 25
6.5%
-4.3%
Q4 24
5.4%
4.0%
Q3 24
-3.3%
2.3%
Q2 24
8.7%
1.2%
Net Margin
OEC
OEC
OMCL
OMCL
Q1 26
3.7%
Q4 25
Q3 25
-14.9%
1.8%
Q2 25
1.9%
1.9%
Q1 25
1.9%
-2.6%
Q4 24
Q3 24
-4.4%
3.1%
Q2 24
4.3%
1.3%
EPS (diluted)
OEC
OEC
OMCL
OMCL
Q1 26
$0.25
Q4 25
$-0.36
$-0.05
Q3 25
$-1.20
$0.12
Q2 25
$0.16
$0.12
Q1 25
$0.16
$-0.15
Q4 24
$0.31
$0.34
Q3 24
$-0.35
$0.19
Q2 24
$0.35
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OEC
OEC
OMCL
OMCL
Cash + ST InvestmentsLiquidity on hand
$60.7M
$239.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$384.6M
$1.3B
Total Assets
$1.9B
$2.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OEC
OEC
OMCL
OMCL
Q1 26
$239.2M
Q4 25
$60.7M
$196.5M
Q3 25
$51.3M
$180.1M
Q2 25
$42.6M
$399.0M
Q1 25
$37.5M
$386.8M
Q4 24
$44.2M
$369.2M
Q3 24
$53.2M
$570.6M
Q2 24
$34.2M
$556.8M
Stockholders' Equity
OEC
OEC
OMCL
OMCL
Q1 26
$1.3B
Q4 25
$384.6M
$1.2B
Q3 25
$401.8M
$1.2B
Q2 25
$466.5M
$1.3B
Q1 25
$466.1M
$1.3B
Q4 24
$474.9M
$1.2B
Q3 24
$476.3M
$1.2B
Q2 24
$503.9M
$1.2B
Total Assets
OEC
OEC
OMCL
OMCL
Q1 26
$2.0B
Q4 25
$1.9B
$2.0B
Q3 25
$2.0B
$1.9B
Q2 25
$2.0B
$2.1B
Q1 25
$2.0B
$2.2B
Q4 24
$1.9B
$2.1B
Q3 24
$2.0B
$2.3B
Q2 24
$1.9B
$2.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OEC
OEC
OMCL
OMCL
Operating Cash FlowLast quarter
$92.9M
$54.5M
Free Cash FlowOCF − Capex
$44.2M
$38.6M
FCF MarginFCF / Revenue
10.7%
12.5%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
4.80×
TTM Free Cash FlowTrailing 4 quarters
$54.8M
$110.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OEC
OEC
OMCL
OMCL
Q1 26
$54.5M
Q4 25
$92.9M
$30.4M
Q3 25
$68.8M
$28.3M
Q2 25
$53.7M
$42.8M
Q1 25
$400.0K
$25.9M
Q4 24
$94.5M
$56.3M
Q3 24
$-30.9M
$22.8M
Q2 24
$29.3M
$58.7M
Free Cash Flow
OEC
OEC
OMCL
OMCL
Q1 26
$38.6M
Q4 25
$44.2M
$22.6M
Q3 25
$27.9M
$18.5M
Q2 25
$11.5M
$31.0M
Q1 25
$-28.8M
$14.8M
Q4 24
$23.5M
$47.2M
Q3 24
$-78.8M
$13.9M
Q2 24
$-25.4M
$49.1M
FCF Margin
OEC
OEC
OMCL
OMCL
Q1 26
12.5%
Q4 25
10.7%
7.2%
Q3 25
6.2%
6.0%
Q2 25
2.5%
10.7%
Q1 25
-6.0%
5.5%
Q4 24
5.4%
15.4%
Q3 24
-17.0%
4.9%
Q2 24
-5.3%
17.8%
Capex Intensity
OEC
OEC
OMCL
OMCL
Q1 26
Q4 25
11.8%
2.5%
Q3 25
9.1%
3.1%
Q2 25
9.0%
4.1%
Q1 25
6.1%
4.1%
Q4 24
16.4%
3.0%
Q3 24
10.3%
3.1%
Q2 24
11.5%
3.5%
Cash Conversion
OEC
OEC
OMCL
OMCL
Q1 26
4.80×
Q4 25
Q3 25
5.18×
Q2 25
5.97×
7.58×
Q1 25
0.04×
Q4 24
Q3 24
2.64×
Q2 24
1.43×
15.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OEC
OEC

Rubber$272.0M66%
Specialties$139.7M34%

OMCL
OMCL

Product revenues$174.8M56%
Service revenues$135.1M44%

Related Comparisons